Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Aquinox Pharmaceuticals ROA 2013-2020 | NLTX

For a detailed definition, formula and example for ROA, check out our new background page here.
Current and historical return on assets (ROA) values for Aquinox Pharmaceuticals (NLTX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
  
Aquinox Pharmaceuticals ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2020-09-30 $-0.03B $0.22B -17.39%
2020-06-30 $-0.09B $0.15B -66.80%
2020-03-31 $-0.08B $0.15B -68.47%
2019-12-31 $-0.07B $0.15B -75.41%
2019-09-30 $-0.07B $0.07B -88.89%
2019-06-30 $-0.02B $0.07B -27.94%
2019-03-31 $-0.02B $0.08B -22.03%
2018-12-31 $-0.03B $0.08B -34.97%
2018-09-30 $-0.04B $0.09B -43.22%
2018-06-30 $-0.04B $0.10B -37.04%
2018-03-31 $-0.06B $0.10B -49.46%
2017-12-31 $-0.05B $0.11B -39.37%
2017-09-30 $-0.05B $0.12B -32.61%
2017-06-30 $-0.04B $0.13B -27.61%
2017-03-31 $-0.04B $0.14B -27.05%
2016-12-31 $-0.04B $0.15B -28.08%
2016-09-30 $-0.03B $0.16B -26.34%
2016-06-30 $-0.03B $0.10B -26.36%
2016-03-31 $-0.02B $0.11B -24.93%
2015-12-31 $-0.02B $0.11B -29.73%
2015-09-30 $-0.02B $0.12B -42.86%
2015-06-30 $-0.03B $0.03B -64.52%
2015-03-31 $-0.03B $0.04B -56.18%
2014-12-31 $-0.02B $0.04B -46.23%
2014-09-30 $-0.02B $0.05B -43.68%
2014-06-30 $-0.02B $0.05B -57.60%
2014-03-31 $-0.02B $0.06B -83.33%
2013-12-31 $-0.01B $0.02B -350.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.568B $0.025B
Neoleukin Therapeutics Inc. is a biopharmaceutical company. It is engaged in creating next generation immunotherapies using de novo protein design technology. The company's product candidate consists of NL-201 which is in clinical stage. Neoleukin Therapeutics Inc., formerly known as Aquinox Pharmaceuticals Inc., is based in Seattle, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $151.012B 10.77
Amgen (AMGN) United States $144.535B 15.11
CSL (CSLLY) Australia $95.617B 0.00
Gilead Sciences (GILD) United States $84.074B 11.18
Vertex Pharmaceuticals (VRTX) United States $60.305B 28.04
Illumina (ILMN) United States $56.971B 78.36
Regeneron Pharmaceuticals (REGN) United States $56.969B 20.21
Moderna (MRNA) United States $49.468B 0.00
Biogen (BIIB) United States $42.139B 7.49
Alexion Pharmaceuticals (ALXN) United States $34.733B 13.84
Seagen (SGEN) United States $34.149B 89.89
BeiGene (BGNE) Cayman Islands $32.525B 0.00
Genmab (GMAB) Denmark $29.056B 34.36
Genmab (GNMSF) Denmark $27.429B 6.32
BioNTech SE (BNTX) Germany $23.690B 0.00
Exact Sciences (EXAS) United States $22.388B 0.00
Incyte (INCY) United States $20.577B 0.00
Alnylam Pharmaceuticals (ALNY) United States $19.566B 0.00
Bio-Rad Laboratories (BIO.B) United States $18.067B 68.51
Horizon Therapeutics Public (HZNP) Ireland $17.922B 25.61
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.372B 0.00
Guardant Health (GH) United States $15.990B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.570B 103.34
CRISPR Therapeutics AG (CRSP) Switzerland $14.120B 0.00
ARGENX SE-ADR (ARGX) Netherlands $13.587B 0.00
Bio-Techne Corp (TECH) United States $13.582B 86.86
QIAGEN (QGEN) Netherlands $12.335B 27.77
Repligen (RGEN) United States $11.691B 165.81
Mirati Therapeutics (MRTX) United States $10.877B 0.00
Twist Bioscience (TWST) United States $9.990B 0.00
Fate Therapeutics (FATE) United States $9.973B 0.00
Adaptive Biotechnologies (ADPT) United States $9.210B 0.00
Denali Therapeutics (DNLI) United States $9.111B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.485B 0.00
Ultragenyx Pharmaceutical (RARE) United States $8.477B 0.00
Ascendis Pharma (ASND) Denmark $8.455B 0.00
Novavax (NVAX) United States $8.148B 0.00
Acceleron Pharma (XLRN) United States $7.982B 0.00
Sarepta Therapeutics (SRPT) United States $7.639B 0.00
Exelixis (EXEL) United States $7.319B 49.15
Galapagos (GLPG) Belgium $7.047B 0.00
Halozyme Therapeutics (HALO) United States $6.525B 301.69
Beam Therapeutics (BEAM) United States $6.312B 0.00
NeoGenomics (NEO) United States $5.970B 1792.33
SWEDISH ORP BIO (BIOVF) Sweden $5.799B 16.96
Blueprint Medicines (BPMC) United States $5.704B 18.88
Amicus Therapeutics (FOLD) United States $5.694B 0.00
Certara (CERT) United States $5.691B 0.00
Emergent Biosolutions (EBS) United States $5.664B 18.59
Eidos Therapeutics (EIDX) United States $4.980B 0.00
Vir Biotechnology (VIR) United States $4.963B 0.00
Intellia Therapeutics (NTLA) United States $4.944B 0.00
Arena Pharmaceuticals (ARNA) United States $4.694B 0.00
China Biologic Products (CBPO) China $4.660B 30.20
Editas Medicine (EDIT) United States $4.495B 0.00
Arvinas (ARVN) United States $4.424B 0.00
Legend Biotech (LEGN) United States $4.187B 0.00
Insmed (INSM) United States $4.018B 0.00
Reata Pharmaceuticals (RETA) United States $3.884B 0.00
MorphoSys AG (MOR) Germany $3.849B 139.33
Alkermes (ALKS) Ireland $3.637B 35.70
Bluebird Bio (BLUE) United States $3.286B 0.00
Global Blood Therapeutics (GBT) United States $3.142B 0.00
I-Mab (IMAB) China $3.027B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.816B 0.00
Intra-Cellular Therapies (ITCI) United States $2.660B 0.00
Sorrento Therapeutics (SRNE) United States $2.480B 0.00
Amarin (AMRN) Ireland $2.460B 0.00
Zymeworks (ZYME) Canada $2.423B 0.00
Arcus Biosciences (RCUS) United States $2.385B 0.00
Seres Therapeutics (MCRB) United States $2.278B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.211B 0.00
Sangamo Therapeutics (SGMO) United States $2.199B 0.00
Ligand Pharmaceuticals (LGND) United States $2.102B 54.46
Genetron Holdings (GTH) China $2.074B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.057B 17.02
Myriad Genetics (MYGN) United States $2.049B 0.00
NantKwest (NK) United States $1.992B 0.00
Viela Bio (VIE) United States $1.979B 0.00
NGM Biopharmaceuticals (NGM) United States $1.959B 0.00
PHARMA MAR SA (PHMMF) Spain $1.936B 0.00
Scholar Rock Holding (SRRK) United States $1.915B 0.00
Revance Therapeutics (RVNC) United States $1.897B 0.00
REGENXBIO (RGNX) United States $1.790B 0.00
Vericel (VCEL) United States $1.771B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.756B 0.00
Inovio Pharmaceuticals (INO) United States $1.711B 0.00
UniQure (QURE) Netherlands $1.695B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.677B 0.00
Castle Biosciences (CSTL) United States $1.578B 0.00
Codexis (CDXS) United States $1.565B 0.00
Heska (HSKA) United States $1.556B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.543B 0.00
Precigen (PGEN) United States $1.502B 0.00
Zealand Pharma (ZEAL) Denmark $1.498B 0.00
Mersana Therapeutics (MRSN) United States $1.484B 0.00
Alector (ALEC) United States $1.421B 0.00
Cellectis S.A (CLLS) France $1.413B 0.00
Cytokineticsorporated (CYTK) United States $1.408B 0.00
Travere Therapeutics (TVTX) United States $1.402B 0.00
Bionano Genomics (BNGO) United States $1.400B 0.00
Coherus BioSciences (CHRS) United States $1.299B 8.59
Frequency Therapeutics (FREQ) United States $1.295B 0.00
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Antibe Therapeutics (ATBPF) Canada $1.215B 0.00
Epizyme (EPZM) United States $1.200B 0.00
Adverum Biotechnologies (ADVM) United States $1.186B 0.00
Northwest Biotherapeutics (NWBO) United States $1.157B 0.00
Mesoblast (MESO) Australia $1.111B 0.00
Athenex (ATNX) United States $1.049B 0.00
Sutro Biopharma (STRO) United States $1.042B 0.00
Cara Therapeutics (CARA) United States $1.000B 0.00
MiMedx (MDXG) United States $0.999B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.982B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.976B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.962B 0.00
Protagonist Therapeutics (PTGX) United States $0.950B 0.00
Morphic Holding (MORF) United States $0.937B 0.00
Pliant Therapeutics (PLRX) United States $0.932B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.927B 0.00
Compugen (CGEN) Israel $0.924B 0.00
Pharming Group (PHGUF) Netherlands $0.914B 24.33
Kadmon Holdings (KDMN) United States $0.852B 0.00
Gritstone Oncology (GRTS) United States $0.841B 0.00
Syros Pharmaceuticals (SYRS) United States $0.840B 0.00
VBI Vaccines (VBIV) United States $0.799B 0.00
Avid Bioservices (CDMO) United States $0.795B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.793B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.773B 0.00
Precision BioSciences (DTIL) United States $0.768B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.763B 38.78
MannKind (MNKD) United States $0.747B 0.00
Curis (CRIS) United States $0.726B 0.00
DBV Technologies S.A (DBVT) France $0.722B 0.00
Merus (MRUS) Netherlands $0.719B 0.00
Celldex Therapeutics (CLDX) United States $0.710B 0.00
AnaptysBio (ANAB) United States $0.704B 0.00
Albireo Pharma (ALBO) United States $0.683B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.672B 0.00
Agenus (AGEN) United States $0.667B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.639B 0.00
MeiraGTx Holdings (MGTX) United States $0.623B 0.00
Affimed (AFMD) Germany $0.614B 0.00
Cel-Sci (CVM) United States $0.597B 0.00
Five Prime Therapeutics (FPRX) United States $0.585B 0.00
Pandion Therapeutics (PAND) United States $0.574B 0.00
Anika Therapeutics (ANIK) United States $0.568B 76.83
Dynavax Technologies (DVAX) United States $0.562B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.559B 0.00
Geron (GERN) United States $0.550B 0.00
Prothena (PRTA) Ireland $0.549B 0.00
Clovis Oncology (CLVS) United States $0.541B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.530B 0.00
FORTE BIOSCIENC (FBRX) United States $0.516B 0.00
Spero Therapeutics (SPRO) United States $0.477B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.476B 0.00
AquaBounty Technologies (AQB) United States $0.471B 0.00
Amryt Pharma (AMYT) United Kingdom $0.470B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.454B 0.00
XOMA (XOMA) United States $0.452B 0.00
Starpharma Holdings (SPHRY) Australia $0.450B 0.00
Cue Biopharma (CUE) United States $0.444B 0.00
AC Immune SA (ACIU) Switzerland $0.443B 0.00
Puma Biotechnology (PBYI) United States $0.439B 0.00
WAVE Life Sciences (WVE) Singapore $0.436B 0.00
BioDelivery Sciences (BDSI) United States $0.435B 20.48
UROGEN PHARMA (URGN) United States $0.429B 0.00
Kala Pharmaceuticals (KALA) United States $0.420B 0.00
AMMO (POWW) United States $0.418B 0.00
Verastem (VSTM) United States $0.416B 0.00
Cardiff Oncology (CRDF) United States $0.410B 0.00
ANI Pharmaceuticals (ANIP) United States $0.400B 10.17
CytomX Therapeutics (CTMX) United States $0.392B 0.00
Innate Pharma S.A (IPHA) France $0.381B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.378B 0.00
Selecta Biosciences (SELB) United States $0.373B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.372B 0.00
Athersys (ATHX) United States $0.370B 0.00
Cellular Biomedicine (CBMG) United States $0.354B 0.00
Arbutus Biopharma (ABUS) United States $0.346B 0.00
Trevena (TRVN) United States $0.342B 0.00
Fortress Biotech (FBIO) United States $0.337B 0.00
NextCure (NXTC) United States $0.336B 0.00
Voyager Therapeutics (VYGR) United States $0.325B 8.34
Kamada (KMDA) Israel $0.318B 14.90
Bellus Health (BLU) Canada $0.313B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.304B 0.00
ChromaDex (CDXC) United States $0.291B 0.00
CorMedix Inc (CRMD) United States $0.289B 0.00
PDL BioPharma (PDLI) United States $0.282B 0.00
IBio (IBIO) United States $0.275B 0.00
Aptinyx (APTX) United States $0.274B 0.00
OSMOTICA PHARM (OSMT) United States $0.270B 0.00
HOOKIPA Pharma (HOOK) United States $0.263B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.246B 0.00
Cogent Biosciences (COGT) United States $0.236B 0.00
Checkpoint Therapeutics (CKPT) United States $0.228B 0.00
Eton Pharmaceuticals (ETON) United States $0.228B 0.00
GENFIT S.A (GNFT) France $0.223B 0.00
Cerecor (CERC) United States $0.217B 0.00
ADMA Biologics Inc (ADMA) United States $0.212B 0.00
Abeona Therapeutics (ABEO) United States $0.211B 0.00
Palatin Technologies (PTN) United States $0.207B 0.00
TELA Bio (TELA) United States $0.203B 0.00
Clearside Biomedical (CLSD) United States $0.203B 0.00
Pluristem Therapeutics (PSTI) Israel $0.202B 0.00
Exicure (XCUR) United States $0.200B 0.00
VolitionRX (VNRX) United States $0.197B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Strongbridge Biopharma (SBBP) United States $0.197B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.196B 0.00
Biofrontera AG (BFRA) Germany $0.196B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.195B 0.00
DiaMedica Therapeutics (DMAC) United States $0.193B 0.00
Idera Pharmaceuticals (IDRA) United States $0.190B 0.00
Nicox SA (NICXF) France $0.182B 0.00
Lumos Pharma (LUMO) United States $0.180B 0.00
Kindred Biosciences (KIN) United States $0.179B 0.00
Theratechnologies (THTX) Canada $0.176B 0.00
Prometic Life Sciences (LMNL) Canada $0.164B 0.00
Oncobiologics (OTLK) United States $0.160B 0.00
VTv Therapeutics (VTVT) United States $0.157B 0.00
Enzo Biochem (ENZ) United States $0.153B 0.00
Dyadic (DYAI) United States $0.153B 0.00
Evogene (EVGN) Israel $0.153B 0.00
Cocrystal Pharma (COCP) United States $0.150B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.149B 0.00
Protalix BioTherapeutics (PLX) Israel $0.149B 0.00
Catalyst Biosciences (CBIO) United States $0.146B 0.00
TRACON Pharmaceuticals (TCON) United States $0.145B 0.00
Orgenesis (ORGS) United States $0.143B 295.50
Aptevo Therapeutics (APVO) United States $0.138B 0.00
Ecology Coatings (ABVC) United States $0.138B 0.00
Synlogic (SYBX) United States $0.133B 0.00
Prima BioMed (IMMP) Australia $0.131B 0.00
Liquidia Technologies (LQDA) United States $0.129B 0.00
PHASEBIO PHARMA (PHAS) United States $0.124B 0.00
AIT Therapeutics (XAIR) United States $0.124B 0.00
Celyad SA (CYAD) Belgium $0.122B 0.00
Applied Genetic Technologies (AGTC) United States $0.122B 0.00
Vascular Biogenics (VBLT) Israel $0.120B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.114B 0.00
Cyclerion Therapeutics (CYCN) United States $0.113B 0.00
Cidara Therapeutics (CDTX) United States $0.108B 0.00
Aytu Bioscience (AYTU) United States $0.100B 0.00
Windtree Therapeutics (WINT) United States $0.100B 0.00
ARAVIVE, INC (ARAV) United States $0.097B 0.00
Organovo Holdings (ONVO) United States $0.097B 0.00
Novogen (KZIA) Australia $0.096B 0.00
Seelos Therapeutics (SEEL) United States $0.092B 0.00
CytRx (CYTR) United States $0.092B 0.00
Stealth BioTherapeutics (MITO) United States $0.082B 39.25
Purple Biotech (PPBT) Israel $0.078B 0.00
CollPlant Holdings (CLGN) Israel $0.077B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.072B 0.00
AnPac Bio-Medical Science (ANPC) China $0.069B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.066B 0.00
Acorda Therapeutics (ACOR) United States $0.064B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.060B 0.00
Genetic Technologies (GENE) Australia $0.059B 0.00
Yumanity Therapeutics (YMTX) United States $0.057B 0.00
Appili Therapeutics (APLIF) Canada $0.057B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.056B 0.00
Vaccinex (VCNX) United States $0.055B 0.00
Edesa Biotech (EDSA) Canada $0.054B 0.00
Happiness Biotech Group (HAPP) China $0.053B 0.00
Soligenix (SNGX) United States $0.053B 0.00
BioCardia (BCDA) United States $0.052B 0.00
Cleveland BioLabs (CBLI) United States $0.050B 0.00
Advaxis (ADXS) United States $0.048B 0.00
Pulmatrix (PULM) United States $0.046B 0.00
Chanticleer Holdings (SONN) United States $0.044B 0.00
AEterna Zentaris (AEZS) United States $0.044B 0.00
ATyr Pharma (LIFE) United States $0.042B 0.00
IMMURON (IMRN) Australia $0.041B 0.00
Alimera Sciences (ALIM) United States $0.039B 0.00
Spherix (AIKI) United States $0.038B 0.00
Prana Biotechnology (ATHE) Australia $0.038B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.037B 0.00
Celsion (CLSN) United States $0.034B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.031B 0.00
Neuralstem (SNCA) United States $0.023B 0.00
Titan Pharmaceuticals (TTNP) United States $0.021B 0.00
Cesca Therapeutics (THMO) United States $0.019B 0.00
GeoVax Labs (GOVX) United States $0.017B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
Lexaria Bioscience (LEXX) Canada $0.015B 0.00
BioPharmX (TMBR) United States $0.012B 0.00
CTD Holdings (CYTH) United States $0.010B 0.00
Enveric Biosciences (ENVB) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.004B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00